1099-1557/asset/PDS_left.gif?v=1&s=f962ae698249deba4dc56217f1bb95eac528fe4d)
1099-1557/asset/PDS_right.gif?v=1&s=44103455c6e4e28135198609bb6a426efee9a51c)
Original Report
You have free access to this content
Design for validation of acute myocardial infarction cases in Mini-Sentinel
Article first published online: 19 JAN 2012
DOI: 10.1002/pds.2314
Copyright © 2012 John Wiley & Sons, Ltd.
Issue
Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 274–281, January 2012
Additional Information
How to Cite
Cutrona, S. L., Toh, S., Iyer, A., Foy, S., Cavagnaro, E., Forrow, S., Racoosin, J. A., Goldberg, R. and Gurwitz, J. H. (2012), Design for validation of acute myocardial infarction cases in Mini-Sentinel. Pharmacoepidem. Drug Safe., 21: 274–281. doi: 10.1002/pds.2314
Publication History
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
Funded by
- FDA through the Department of Health and Human Services. Grant Number: HHSF223200910006I
REFERENCES
- 1, , , et al. Developing the Sentinel System - A National Resource for Evidence Development. N Engl J Med 2011; 364: 498–499.
- 2The Sentinel Initiative: Access to Electronic Healthcare Data for More than 25 Million Lives; Achieving FDAAA Section 905 Goal One. July 2010. http://www.fda.gov/downloads/Safety/FDAsSentinelInitiative/UCM233360.pdf [31 January 2011].
- 3, , , et al. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf 2012; 21(S1): 12–17.
- 4, , , et al. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf 2012; 21(S1): 23–31.
- 5, , , et al. Mini-Sentinel Systematic Validation of Health Outcome of Interest Acute Myocardial Infarction Cases Report. http://mini-sentinel.org/work_products/Validation_HealthOutcomes/Mini-Sentinel-Validation-of-AMI-Cases.pdf. [Accessed 4 May 2011].
- 6, , , et al. A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent. Pharmacoepidemiol Drug Saf 2012; 21(S1): 282–290.
- 7, , . Systematic literature review for evaluation of myocardial infarction. Final report prepared for the Foundation for the National Institutes of Health via the Observational Medical Outcomes Partnership (OMOP). United Biosource Corporation: Lexington, MA, 2009.
- 8, , . Systematic evaluation of health outcome of interest definitions in observational studies and clinical definitions for the Observational Medical Outcomes Partnership: Myocardial infarction report. RTI International; Research Triangle Park, NC, 2009.
- 9, , . A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J 2002; 144: 290–296.
- 10, , , et al. An algorithm to identify incident myocardial infarction using Medicaid data. Pharmacoepidemiol Drug Saf 2009; 18: 1064–1071.
- 11, , , et al. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 2001; 30(Suppl 1): S30–34.
- 12, , , et al. Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J 2004; 148: 99–104.
- 13, , , et al. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 2003; 56: 124–130.
- 14, , , et al. Hospitalized cardiovascular diseases in neovascular age-related macular degeneration. Arch Ophthalmol 2008; 126: 1280–1286.
- 15, , , et al. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005; 12: 132–137.
- 16, , , et al. Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database. J Gen Intern Med 1999; 14: 555–558.
- 17, , , et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 2004; 109: 2068–2073.
- 18, , , et al. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database. Pharmacoepidemiol Drug Saf 2008; 17: 842–852.
- 19, , , et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf 2010; 19: 596–603.
- 20, , , et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010; 362: 2155–2165.
- 21Department of Health and Human Services, Office of the Secretary. Standards for Privacy of Individually Identifiable Health Information; Final Rule. In: 45 CFR Parts 160 and 164: Federal Register; 2002: 53182–53273.
- 22, , , et al. A 30-year perspective (1975–2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes 2009; 2: 88–95.
- 23, , . HIPAA and Common Rule Compliance in the Mini-Sentinel Pilot. http://mini-sentinel.org/work_products/About_Us/HIPAA_and_CommonRuleCompliance_in_the_Mini-SentinelPilot.pdf [Accessed 26 January 2011].
- 24, , , et al. Universal definition of myocardial infarction. Circulation 2007; 116: 2634–2653.
- 25, , , et al. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart 2008; 94: 1335–1341.
- 26, , , et al. Standardisation of cardiac troponin I measurement: past and present. Pathology 2010; 42: 402–408.